244 related articles for article (PubMed ID: 33826081)
1. Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of Japan.
Funahashi T; Koyama T; Hagiya H; Harada K; Iinuma S; Ushio S; Zamami Y; Niimura T; Shinomiya K; Ishizawa K; Sendo T; Hinotsu S; Kano MR
Drug Saf; 2021 May; 44(5):531-539. PubMed ID: 33826081
[TBL] [Abstract][Full Text] [Related]
2. International Trends in Adverse Drug Event-Related Mortality from 2001 to 2019: An Analysis of the World Health Organization Mortality Database from 54 Countries.
Koyama T; Iinuma S; Yamamoto M; Niimura T; Osaki Y; Nishimura S; Harada K; Zamami Y; Hagiya H
Drug Saf; 2024 Mar; 47(3):237-249. PubMed ID: 38133735
[TBL] [Abstract][Full Text] [Related]
3. Use of ICD-10-CM T codes in hospital claims data to identify adverse drug events in Taiwan.
Cheng YF; Cheng CY; Wang SH; Lin YT; Tsai TC
J Clin Pharm Ther; 2021 Apr; 46(2):476-483. PubMed ID: 33210301
[TBL] [Abstract][Full Text] [Related]
4. [Deaths from adverse drug events in Brazil: Mortality Information System as a source of information].
Martins ACM; Giordani F; Gonçalves MC; Guaraldo L; Rozenfeld S
Cad Saude Publica; 2022; 38(8):e00291221. PubMed ID: 36169445
[TBL] [Abstract][Full Text] [Related]
5. Fall-related mortality trends in older Japanese adults aged ≥65 years: a nationwide observational study.
Hagiya H; Koyama T; Zamami Y; Tatebe Y; Funahashi T; Shinomiya K; Kitamura Y; Hinotsu S; Sendo T; Rakugi H; Kano MR
BMJ Open; 2019 Dec; 9(12):e033462. PubMed ID: 31831549
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Nontuberculous Mycobacterial Disease Mortality Rate in Japan: A Nationwide Observational Study, 1997-2016.
Harada K; Hagiya H; Funahashi T; Koyama T; Kano MR; Otsuka F
Clin Infect Dis; 2021 Jul; 73(2):e321-e326. PubMed ID: 32556251
[TBL] [Abstract][Full Text] [Related]
7. Trends in Head and Neck Cancer Mortality from 1999 to 2019 in Japan: An Observational Analysis.
Higashionna T; Harada K; Maruo A; Niimura T; Tan E; Vu QT; Kawabata T; Ushio S; Hamano H; Kajizono M; Zamami Y; Ishizawa K; Harada K; Hinotsu S; Kano MR; Hagiya H; Koyama T
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568602
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
9. Trends in the amyloidosis mortality rate in Japan: A nationwide observational study from 1998 to 2019.
Harada K; Hagiya H; Koyama T; Otsuka F
Geriatr Gerontol Int; 2022 Mar; 22(3):246-250. PubMed ID: 35052016
[TBL] [Abstract][Full Text] [Related]
10. Trends in hepatitis C virus-associated mortality rates in Japan, 1998-2017.
Hagiya H; Koyama T; Deguchi M; Minato Y; Miura S; Funahashi T; Teratani Y; Zamami Y; Shinomiya K; Kitamura Y; Sendo T; Hinotsu S; Kano M
J Gastroenterol Hepatol; 2021 Sep; 36(9):2486-2492. PubMed ID: 33837565
[TBL] [Abstract][Full Text] [Related]
11. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
Sonawane KB; Cheng N; Hansen RA
J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
[TBL] [Abstract][Full Text] [Related]
12. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.
Hougland P; Xu W; Pickard S; Masheter C; Williams SD
Med Care; 2006 Jul; 44(7):629-36. PubMed ID: 16799357
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug events in German hospital routine data: A validation of International Classification of Diseases, 10th revision (ICD-10) diagnostic codes.
Kuklik N; Stausberg J; Jöckel KH
PLoS One; 2017; 12(11):e0187510. PubMed ID: 29095926
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006.
Shepherd G; Mohorn P; Yacoub K; May DW
Ann Pharmacother; 2012 Feb; 46(2):169-75. PubMed ID: 22253191
[TBL] [Abstract][Full Text] [Related]
15. Secular Trends in Systemic Sclerosis Mortality in the United States from 1981 to 2020.
Li JX
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429809
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug events in the outpatient setting: an 11-year national analysis.
Bourgeois FT; Shannon MW; Valim C; Mandl KD
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):901-10. PubMed ID: 20623513
[TBL] [Abstract][Full Text] [Related]
17. Trends in sarcoidosis mortality rate in Japan from 2001 to 2020: A population-based study.
Harada K; Hagiya H; Koyama T; Otsuka F
Respir Med; 2022 May; 196():106828. PubMed ID: 35349955
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of adverse drug events and medication errors in four nursing homes in Japan: the Japan Adverse Drug Events (JADE) Study.
Ayani N; Oya N; Kitaoka R; Kuwahara A; Morimoto T; Sakuma M; Narumoto J
BMJ Qual Saf; 2022 Dec; 31(12):878-887. PubMed ID: 35450935
[TBL] [Abstract][Full Text] [Related]
19. Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates.
Zaccardi F; Dhalwani NN; Webb DR; Davies MJ; Khunti K
Diabetologia; 2018 Jul; 61(7):1592-1602. PubMed ID: 29717336
[TBL] [Abstract][Full Text] [Related]
20. Trends in Premature Deaths Among Adults in the United States and Latin America.
Chen Y; Freedman ND; Rodriquez EJ; Shiels MS; Napoles AM; Withrow DR; Spillane S; Sigel B; Perez-Stable EJ; Berrington de González A
JAMA Netw Open; 2020 Feb; 3(2):e1921085. PubMed ID: 32049297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
